NAGE - NASDAQ

Niagen Bioscience Inc

NAGE·NASDAQ

$3.46

-2.1%

HealthcareBiotechnology

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$275.97M

EPS0.2200

P/E Ratio15.75

Earnings Date08/05/2026

106.41M

Assets

56%

3Y+97.0%

5Y+177.0%

10Y+439.0%

29.87M

Total Liabilities

35%

3Y+18.0%

5Y+36.0%

10Y+206.0%

76.53M

Total Equity

66%

3Y+167.0%

5Y+366.0%

10Y+667.0%

Niagen Bioscience Inc Funding & Solvency Profile

NAGE · NASDAQ

Current Assets

Cash & Cash Equivalents64.79M

Net Receivables9.74M

Inventory20.42M

Other Current Assets1.85M

Total Current Assets97 M

Non-Current Assets

Property, Plant & Equipment3.52M

Goodwill & Intangible Assets5.66M

Long-Term Investments0.00

Other Non-Current Assets425.00K

Total Non-Current Assets4 M

Total Assets

106.41M

Financial Health Analysis

Current Ratio

4.86x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.39x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

77 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

91% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Niagen Bioscience Inc Balance Sheet

NAGE • NASDAQ

Niagen Bioscience Inc Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	64.8M	44.5M	27.2M	20.3M	28M	16.5M	18.6M	22.4M	45.4M	1.6M	5.5M	4M	2.3M	520K	420.2K	2.2M	471.4K	1.1M	580.0
Cash & Short-Term Investments	64.8M	44.5M	27.2M	20.3M	28M	16.5M	18.6M	22.4M	45.4M	1.6M	5.5M	4M	2.3M	520K	420.2K	2.2M	471.4K	1.1M	580.0
Net Receivables	9.7M	7.8M	5.2M	8.5M	5.2M	2.7M	2.2M	4.4M	5.3M	5.9M	2.5M	1.9M	1.1M	1.9M	723.7K	1M	497.9K	349.1K	0.0
Accounts Receivables	9.7M	7.8M	5.2M	8.5M	5.2M	2.7M	2.2M	4.4M	5.3M	5.9M	2.5M	1.9M	838.8K	1.9M	723.7K	1M	497.9K	349.1K	0.0
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56K	0.0	0.0	0.0	0.0	215K	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	20.4M	9.2M	14.5M	14.7M	13.6M	11.7M	11.5M	8.2M	5.8M	7.9M	8.2M	3.7M	2.2M	5.2M	2.9M	1.4M	922.8K	711.6K	0.0
Prepaids	0.0	0.0	0.0	0.0	1.9M	1.1M	996K	577K	655K	311.5K	373.6K	292.9K	271.4K	261.3K	903.9K	244K	115.8K	112.6K	0.0
Other Current Assets	1.9M	2.6M	2.6M	3.1M	200K	200K	200K	877K	0.0	18.3K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Assets	96.8M	64.1M	49.5M	46.6M	48.9M	32.2M	33.5M	36.5M	57.2M	15.7M	16.5M	9.9M	5.8M	7.9M	5M	4.9M	2M	2.3M	580.0
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	3.5M	3.4M	4.5M	6.3M	7.4M	4.4M	4.7M	3.6M	2.9M	1.8M	1.8M	1.3M	1.1M	936.4K	1.2M	1.3M	1.2M	1.3M	0.0
Intangible Assets	5.7M	359K	510K	671K	857K	1.1M	1.3M	1.5M	1.7M	486K	354K	296.1K	201.7K	136.2K	100.1K	277.9K	321.5K	445.3K	0.0
Goodwill & Intangible Assets	5.7M	359K	510K	671K	857K	1.1M	1.3M	1.5M	1.7M	486K	354K	296.1K	201.7K	136.2K	100.1K	277.9K	321.5K	445.3K	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3K	0.0	0.0	1.9M	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	425K	368K	383K	497K	723K	625K	762K	566K	1M	1.7M	58.9K	57.4K	43.5K	34.8K	44.2K	31.4K	32.2K	45K	0.0
Total Non-Current Assets	9.6M	4.2M	5.4M	7.5M	8.9M	6.1M	6.7M	5.7M	5.5M	4M	2.2M	1.6M	3.2M	1.1M	1.3M	1.6M	1.6M	1.8M	0.0
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1K	397.0	-303.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	106.4M	68.3M	55M	54.1M	57.8M	38.4M	40.2M	42.2M	62.7M	19.8M	18.7M	11.5M	9M	9M	6.3M	6.5M	3.6M	4.1M	580.0
LIABILITIES
CURRENT LIABILITIES
Total Payables	10.8M	8.5M	10.2M	9.7M	10.4M	9.4M	9.6M	9.5M	3.8M	6M	6.2M	3.5M	1.4M	3.4M	2.3M	514.6K	1.7M	1.6M	400.0
Accounts Payable	10.8M	8.5M	10.2M	9.7M	10.4M	9.4M	9.6M	9.5M	3.7M	6M	6.2M	3.5M	1.4M	3.4M	2.3M	514.6K	548.3K	444.3K	400.0
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2M	1.2M	0.0
Accrued Expenses	0.0	7.8M	9.5M	7.3M	6.5M	6.1M	4.4M	4.4M	3.6M	2.2M	1.3M	853.7K	656.7K	876.2K	756K	371K	270.3K	338.1K	0.0
Short Term Debt	1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5M	223.4K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	994K	702K	696K	548K	620K	853K	173K	196K	255.5K	219.7K	148.3K	138.9K	77.3K	77.4K	78.6K	28.4K	78.5K	0.0
Deferred Revenue	0.0	611K	195K	157K	161K	278K	169K	275K	314K	389K	272K	234.4K	546K	310.3K	199.7K	112.4K	162.1K	34.3K	0.0
Other Current Liabilities	8.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114K	76.2K	39.5K	69.5K	55.6K	71K	59.7K	62.7K	0.0	0.0	0.0
Total Current Liabilities	19.9M	17.9M	20.6M	17.9M	17.6M	16.5M	15.1M	14.4M	8.1M	8.9M	9.6M	5M	2.8M	4.8M	3.3M	1.1M	2.2M	2.1M	400.0
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3M	2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	2.7M	2.6M	3.3M	4M	4.3M	4.4M	3.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	200.9K	233.8K	284.4K	186.3K	0.0
Other Non-Current Liabilities	5.5M	0.0	0.0	0.0	0.0	0.0	0.0	477K	492K	565K	98K	137.5K	203K	129.9K	0.0	0.0	0.0	0.0	0.0
Total Non-Current Liabilities	10M	4.2M	5.9M	7.5M	8.5M	5.5M	4.7M	614K	802K	908.6K	3.9M	2.5M	483.3K	278.2K	365.6K	431.9K	330.2K	260.6K	0.0
Capital Lease Obligations	1.8M	2.7M	3.3M	4.3M	4.7M	1.6M	1.7M	310K	506K	599.1K	664.3K	571.3K	419.2K	225.6K	242.1K	276.6K	74.3K	152.8K	0.0
Total Liabilities	29.9M	22.2M	26.5M	25.4M	26.1M	21.9M	19.8M	15.1M	8.9M	9.8M	13.5M	7.5M	3.3M	5M	3.7M	1.6M	2.5M	2.3M	400.0
SHAREHOLDERS' EQUITY
Common Stock	79K	77K	75K	74K	68K	62K	60K	55K	55K	37.5K	36K	105.3K	104.5K	92.1K	72.9K	60.9K	28.8K	28.8K	1.4K
Additional Paid-In Capital	241M	227.9M	218.8M	214.1M	200.6M	158.2M	142.3M	116.9M	110.4M	55.2M	47.5M	43.4M	39.7M	33.6M	20.5M	15M	9.1M	8.9M	38.6K
Retained Earnings	-164.5M	-181.9M	-190.5M	-185.5M	-169M	-141.8M	-121.9M	-89.8M	-56.6M	-45.2M	-42.3M	-39.5M	-34.1M	-29.7M	-18.1M	-10.2M	-8.1M	-7.2M	-39.8K
Accumulated Other Comprehensive Income/Loss	-9K	-4K	-4K	-3K	-2K	-3K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	76.5M	46.1M	28.5M	28.7M	31.7M	16.4M	20.4M	27.2M	53.8M	10M	5.3M	4M	5.7M	4M	2.6M	4.9M	1M	1.7M	180.0
Total Equity	76.5M	46.1M	28.5M	28.7M	31.7M	16.4M	20.4M	27.2M	53.8M	10M	5.3M	4M	5.7M	4M	2.6M	4.9M	1M	1.7M	180.0
SUMMARY
Total Liabilities & Equity	106.4M	68.3M	55M	54.1M	57.8M	38.4M	40.2M	42.2M	62.7M	19.8M	18.7M	11.5M	9M	9M	6.3M	6.5M	3.6M	4.1M	580.0
Total Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3K	0.0	0.0	1.9M	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	2.8M	2.7M	3.3M	4.3M	4.7M	1.6M	1.7M	310K	506K	599.1K	5.5M	2.8M	419.2K	225.6K	242.1K	276.6K	74.3K	152.8K	0.0
Net Debt	-62M	-41.9M	-23.9M	-16M	-23.3M	-14.9M	-16.9M	-22.1M	-44.9M	-1M	-11.5K	-1.2M	-1.8M	-294.4K	-178.1K	-1.9M	-397.1K	-972.7K	-580.0
Shares Outstanding	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100	79,806,100

SEC Filings

NAGE - Filing history and reports

No SEC filings available for NAGE

Related Guides

Blog Categories

Continue your NAGE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.